ATC codes:
J04AK06
EMLc
Indication
Multi-drug resistant Mycobacterium tuberculosis
ICD11 code:
ML32.00
INN
Delamanid
Medicine type
Chemical agent
List type
Complementary
Additional notes
Medicines for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.
Formulations
Oral > Solid:
50 mg tablet ;
25 mg tablet (dispersible)
(EMLc)
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Main patent is active in several jurisdictions. For more information on specific patents and
license status for developing countries visit www.MedsPal.org
Read more
about patents.
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the removal of the age restrictions from the listing of delamanid on the EML and EMLc, consistent with the recommendations for use of delamanid in current WHO guidelines for management of tuberculosis in children and adolescents.